| Literature DB >> 33568230 |
Ericka P von Kaeppler1, Claire Donnelley1, Syed H Ali1, Heather J Roberts1, John M Ibrahim1, Hao-Hua Wu1, Edmund N Eliezer2, Travis C Porco3,4,5, Billy T Haonga2, Saam Morshed1, David W Shearer6.
Abstract
BACKGROUND: Open tibia fractures are a major source of disability in low- and middle-income countries (LMICs) due to the high incidence of complications, particularly infection and chronic osteomyelitis. One proposed adjunctive measure to reduce infection is prophylactic local antibiotic delivery, which can achieve much higher concentrations at the surgical site than can safely be achieved with systemic administration. Animal studies and retrospective clinical studies support the use of gentamicin for this purpose, but no high-quality clinical trials have been conducted to date in high- or low-income settings.Entities:
Keywords: Antibiotics; Fracture-related infection; Gentamicin; Global health; Open tibia fracture; Orthopaedic surgery
Year: 2021 PMID: 33568230 PMCID: PMC7874655 DOI: 10.1186/s40814-021-00766-7
Source DB: PubMed Journal: Pilot Feasibility Stud ISSN: 2055-5784